Privately-held French drugmaker Servier has announced the inauguration of its first unit dedicated to the production of ...

San Diago, USA-based Acadia Pharmaceuticals yesterday announced it has entered into an exclusive worldwide license agreement with Denmark’s Saniona for the development and commercialization of SAN711, ...

The US Food and Drug Administration has received new reports of hematologic malignancies, including life-threatening cases of ...

The US Food and Drug Administration (FDA) yesterday announced its Fiscal Year 2025 Generic Drug User Fee Amendments (GDUFA).

Munich, Germany headquartered contract development and manufacturing organization (CDMO) Adragos Pharma has acquired Baccinex ...

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

Kronos Bio has announced a major restructuring, including significant workforce reductions, as it grapples with clinical and ...

Johnson & Johnson (J&J) has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies ...

UK-based drugmaker Advanz Pharma has announced that following the grant of a temporary suspension, as announced on last month ...

Japanese drugmaker Eisai today that the humanized antisoluble aggregated amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab) has been launched in South Korea.

The European Medicines Agency has approved Tevimbra (tislelizumab) in combination with chemotherapy for advanced throat and ...

After trading closed yesterday, Exelixis revealed that the US Food and Drug Administration (FDA) has notified the company ...